An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors.
about
Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in miceAxl as a mediator of cellular growth and survivalGankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma.Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma.Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival.Advances in the targeted therapy of liposarcoma.Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesisAXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcomaAdvances in sarcoma genomics and new therapeutic targets.Increased H3K9me3 drives dedifferentiated phenotype via KLF6 repression in liposarcoma.Characterization of liposarcoma cell lines for preclinical and biological studies.Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell linesEpigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growthSAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma.Hypothesis: The Intratumoral Immune Response against a Cancer Progenitor Cell Impacts the Development of Well-Differentiated versus Dedifferentiated Disease in LiposarcomaG protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma.Frequent amplification of receptor tyrosine kinase genes in welldifferentiated/ dedifferentiated liposarcoma.Novel systemic therapies in advanced liposarcoma: a review of recent clinical trial resultsLiposarcoma: Multimodality Management and Future Targeted Therapies.Liposarcoma: molecular targets and therapeutic implications.Peritoneal sarcomatosis: site of origin for the establishment of an in vitro and in vivo cell line model to study therapeutic resistance in dedifferentiated liposarcoma.Recent translational research into targeted therapy for liposarcoma.MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.Analysis of the intratumoral adaptive immune response in well differentiated and dedifferentiated retroperitoneal liposarcoma.Heterogeneity and immunophenotypic plasticity of malignant cells in human liposarcomas.H3K9me3-mediated repression of KLF6: Discovering a novel tumor suppressor in liposarcoma using a systematic epigenomic approach.Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma.Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?Follicle-stimulating hormone receptor expression in soft tissue sarcomas.Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma.Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression.miR-133a function in the pathogenesis of dedifferentiated liposarcoma.
P2860
Q54902550-6C8767AF-6CC8-4868-8DD8-7A027008EEC0Q54902551-87E016E7-A125-4E4C-A223-C5D114FAAC35Q54902552-4371E9C0-FACC-47CF-B2B8-8EB1A164CE0CQ54902553-29BF1955-DB8F-4FBA-93D6-45990F304D15Q54902554-14BD9100-2D07-455C-A82D-550102A9F462Q54902555-B2D78175-0B2A-43DA-A442-D636A13CAFDEQ54902557-FD5B8D99-F730-4DE1-8E25-96B56F48ADCBQ54902558-F8031F61-C46A-4AD8-BF88-950AC7AF6418Q54902559-A28F7D1A-5E03-45BB-9B20-D4D3684116C5Q54902560-D46A1EBB-E5C0-4DC4-A999-CAC7A523D697Q54902562-3CA4CE19-092C-4DE6-A69A-B14851F702C5Q54902563-ECF06DEA-2002-4EC3-B0AB-08C57E4D358AQ54902564-E15B130D-C5C1-4CE5-9C80-F50FFCECE5ECQ54902565-56CE56C7-8BFD-43B5-B98D-CB5CD158E532Q54902566-3B567F34-EDDA-4A49-A458-0C9BF84CBDB5Q54902567-C41F848B-FBCD-4844-86DE-22E90188B6B0Q54902568-0AB22C57-9829-4611-AC06-F8A01E45A6A7Q54902569-3798C67D-1627-4F91-9217-DD4F3D941772Q54902570-2C5C90B7-D05D-46C0-9FAA-59B0EF4B7886Q54902571-1B59F26A-9A9A-4269-8788-BC74A137ACA6
P1343
Q28389770-4552B78D-3B15-4A66-8565-46656A98B094Q34619118-71A00EEA-0E0A-4F16-9E07-BCCADC356365Q34619226-8E488FE5-CB50-4E93-91ED-6C1AA998AB98Q34629045-AFF0F439-4D2D-4BD0-A88D-0C204C0A8FDBQ34633368-A431D911-DA94-484C-A154-B5B7314FE4B4Q34952133-A4633B2C-E8B2-4E08-BB0D-253436A5EB6EQ35818801-92F5064D-7CEB-4A2A-B920-ECA530FD135DQ35843071-8796B319-406D-4321-A656-A4C70B6E7FFEQ35904618-C987A2F4-4E5E-45D5-A0F9-42405D11E922Q35993346-55DD441B-F413-491F-9BF3-41F8EB5E9DCFQ36040449-77C5E254-97DC-4F7E-B168-05EA7FBE46CAQ36111589-ACECBC50-061A-40F0-BB25-32AC3B0638BDQ36438319-5C56E4CD-D018-4AD2-BF24-67485F458861Q36548712-FC2EE487-6E06-4DF9-8983-D476205A4B72Q36642763-02B7DFD9-FE02-41F9-B7C5-7BDB52A74661Q36989914-5E96F8F4-6240-496C-9424-F79347948FCCQ37396062-555394D8-E35A-4FDD-9476-59B26D5DDC5EQ37706527-416B48BC-BB79-478C-920C-B915880CCED2Q38161734-409589E1-7509-45B5-AE34-ACAF5F97189AQ38824691-D3D1F483-708A-4A7B-993F-4771A5552689Q38833050-2CA66972-1BD0-4D02-BC1C-1EEF376E1F35Q38835065-4CFF6236-6F99-4E96-9D03-6B0B9864E05DQ39265801-4F8D98F5-CDD8-4ED7-978A-F5499C431A01Q39393414-EC817788-E2A6-4F64-9D05-98F57506E4E2Q39724344-4C59EA55-9BD9-4BAC-8F38-F3932F9B18FFQ41370229-2CF5A825-23BF-4E6D-98F7-A9124A6CFE26Q42544953-155194E9-FAC2-4251-8657-A477616348FFQ42705253-641355DD-ED6C-4FC1-BC4C-956D9CC0F42CQ43991475-6DCE09E3-3319-4A7D-962E-7E0C269073A9Q44650759-0BC7D72B-D956-42E0-B77E-1DE9A8432B57Q46247480-28FFE7AB-AABA-4382-BB65-CDF5857749D1Q47148669-55947F91-6253-4B8A-9BD6-0E0BF149C6BDQ52766495-454653D5-25E9-4400-B48C-D555CA4FD197Q55443461-E5672865-FE27-4FCA-854E-906FB16620F8
P2860
An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
An experimental model for the ...... ble tyrosine kinase receptors.
@ast
An experimental model for the ...... ble tyrosine kinase receptors.
@en
An experimental model for the ...... ble tyrosine kinase receptors.
@nl
type
label
An experimental model for the ...... ble tyrosine kinase receptors.
@ast
An experimental model for the ...... ble tyrosine kinase receptors.
@en
An experimental model for the ...... ble tyrosine kinase receptors.
@nl
prefLabel
An experimental model for the ...... ble tyrosine kinase receptors.
@ast
An experimental model for the ...... ble tyrosine kinase receptors.
@en
An experimental model for the ...... ble tyrosine kinase receptors.
@nl
P2093
P2860
P4510
P1476
An experimental model for the ...... ble tyrosine kinase receptors.
@en
P2093
Andre M Oliveira
Delores H López-Terrada
Jeffery Liu
Kari Brewer
Pingyu Zhang
Roman Belousov
Svetlana Bolshakov
Theresa Nguyen
Tingsheng Peng
P2860
P2888
P304
P356
10.1038/LABINVEST.2010.185
P577
2010-11-08T00:00:00Z
P5875
P6179
1008419137